*Includes a maintained Dermatology Life Quality Index (DLQI) and relief from itch, burning and pain improvements from baseline.3,4
1. Janssen-Cilag Ltd. TREMFYA® Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc (last accessed: October 2020). 2. Griffiths CEM et al. Poster presented at: 37th Fall Clinical Dermatology Conference; October 18-21, 2018; Las Vegas, Nevada. 3. Blauvelt A et al. J Am Acad Dermatol 2017; 76(3):405–417. 4. Griffiths CEM et al. Poster presented at: 39th Fall Clinical Dermatology Conference; October 17-20, 2019; Las Vegas, Nevada. 5. Griffiths CEM et al. Poster presented at the 16th Annual Coastal Dermatology Symposium. October 15-16; 2020 New Jersey, USA. 6. Papp KA et al. Eur Acad Dermatol Venereol. 2018; 32(9):1515–1522.
Item Code: CP-186346 Date of Preparation: November 2020